SCHEMBL23950843

SCHEMBL23950843

Cc1noc(C)c1[C@@H](c1ccccc1)N1CC(N)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.55
NPY2R P49146 1/20 0.43
ALDH1A1 P00352 4/20 0.40
USP2 O75604 3/20 0.40
CYP3A4 P08684 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP2D6 P10635 2/20 0.40
TSHR P16473 2/20 0.40
NAAA Q02083 1/20 0.38
BRD4 O60885 4/20 0.37
BRD2 P25440 2/20 0.37
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
CYP1A2 P05177 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72466 0.77 OPRM1 (0.48) ALDH1A1USP2CYP3A4MEN1KMT2A
Hydrochloric Acid SCHEMBL10506432 0.75 OPRM1 (0.47) ALDH1A1USP2CYP3A4MEN1KMT2A
Hydrochloric Acid SCHEMBL10401309 0.75 OPRM1 (0.47) ALDH1A1USP2CYP3A4MEN1KMT2A
SCHEMBL30220784 0.72 GAA (0.69) GAANPY2RALDH1A1USP2CYP3A4
SCHEMBL2628020 0.70 GAA (0.65) GAANPY2RALDH1A1KMT2ACYP2D6
SCHEMBL23950835 0.69 OPRM1 (0.39) GAAALDH1A1MEN1KMT2ACYP2D6
SCHEMBL5514265 0.64 CYP2D6 (0.41) USP2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL6843039 0.63 OPRM1 (0.53) MEN1KMT2ACYP2D6TSHRL3MBTL1
SCHEMBL2628017 0.62 GAA (0.56) GAANPY2RALDH1A1MEN1KMT2A
SCHEMBL18614900 0.62 L3MBTL3 (0.50) ALDH1A1CYP3A4MEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203044-A1 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 US disclosed
US-20230203044-A1 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 US disclosed
WO-2021209552-A1 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY JANSSEN PHARMACEUTICA NV (BE) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203044-A1 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME NLRP3, PYCARD, NLRP1 GAA 3781/4885NPY2R 1605/4885ALDH1A1 268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.